Company intelligence / Profile preview

Stealth Startup

Needham, Massachusetts, USAstealthstartup.com ↗

Ownership: Private
Development stage: Commercial

Overview

Stealth BioTherapeutics is developing therapies targeting mitochondrial dysfunction. Its lead candidate has been evaluated in multiple clinical trials for rare genetic and common age-related diseases. No FDA-approved treatments yet exist for these indications.

Therapeutic areas: OphthalmologyRare Diseases
Modalities: Small moleculePeptide
Industry: Biotech

Partnerships

Works with patient advocacy organizations

Beyond the preview

Go deeper on Stealth Startup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stealth Startup.

Explore the full profile